Andreas Huettmann (A Hüttmann, Andreas Hüttmann)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Morgane Cheminant, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Laurent Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc P E André, Norma C Gutiérrez, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandra Tucci, Patrick Fogarty, Hassan Farhat, Julie Abraham, Wajed Abarah, Fatiha Belmecheri, Vincent Ribrag, Marie-Hélène Delfau-Larue, Anne-Ségolène Cottereau, Emmanuel Itti, Ju Li, Richard Delarue, Laurence L de Leval, Judith Trotman, Emmanuel Bachy
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Morgane Cheminant, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Laurent Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc P E André, Norma C Gutiérrez, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandra Tucci, Patrick Fogarty, Hassan Farhat, Julie Abraham, Wajed Abarah, Fatiha Belmecheri, Vincent Ribrag, Marie-Hélène Delfau-Larue, Anne-Ségolène Cottereau, Emmanuel Itti, Ju Li, Richard Delarue, Laurence L de Leval, Judith Trotman, Emmanuel Bachy
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Morgane Cheminant, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Laurent Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc P E André, Norma C Gutiérrez, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandra Tucci, Patrick Fogarty, Hassan Farhat, Julie Abraham, Wajed Abarah, Fatiha Belmecheri, Vincent Ribrag, Marie-Hélène Delfau-Larue, Anne-Ségolène Cottereau, Emmanuel Itti, Ju Li, Richard Delarue, Laurence L de Leval, Judith Trotman, Emmanuel Bachy
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Christian Hoffmann, Toke Ringbaek, Anja Eckstein, Wolfgang Deya, Alina Santiago, Martin Heintz, Wolfgang Lübcke, Frank Indenkämpen, Wolfgang Sauerwein, Andrea Flühs, Claudia H D Le Guin, Andreas Huettmann, Julia von Tresckow, Sophia Göricke, Cornelius Deuschl, Sourour Moliavi, Christoph Pöttgen, Thomas Gauler, Nika Guberina, Patricia Johansson, Nikolaos Bechrakis, Martin Stuschke, Maja Guberina
Long-Term Follow-Up of Patients with Conjunctival Lymphoma after Individualized Lens-Sparing Electron Radiotherapy: Results from a Longitudinal Study. Cancers 15 (22) (2023)
Jakoba Johanna Eertink, Gerben J C Zwezerijnen, Martijn Heymans, Simone Pieplenbosch, Sanne Elisabeth Wiegers, Ulrich Dührsen, Andreas Huettmann, Lars Kurch, Christine Hanoun, Pieternella J Lugtenburg, Sally F Barrington, N George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sandor Czibor, Tamás Györke, Martine E D Chamuleau, Otto S Hoekstra, Henrica C W de Vet, Ronald Boellaard, Josée J M Zijlstra-Baalbergen
Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma. Blood (2023)
Georg Hess, Andreas Huettmann, Mathias Witzens-Harig, Martin H Dreyling, Ulrich Keller, Reinhard Marks, Thomas Ernst, Christiane Pott, Andreas Viardot, Fabian Frontzek, Marcel Trautmann, Christian Ruckes, Oliver Deuster, Andreas Rosenwald, Matthias Theobald, Georg Lenz
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial. British journal of haematology 198 (3) (2022)
Jakoba Johanna Eertink, Gerben J C Zwezerijnen, Sanne Elisabeth Wiegers, Simone Pieplenbosch, Martine E D Chamuleau, Pieternella J Lugtenburg, Daphne de Jong, Bauke Ylstra, Matias Mendeville, Ulrich Dührsen, Christine Hanoun, Andreas Huettmann, Julia Richter, Wolfram Klapper, Yvonne Ws Jauw, Otto S Hoekstra, Henrica C W de Vet, Ronald Boellaard, Josée J M Zijlstra-Baalbergen
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma. Blood advances (2022)
Robert Seifert, David Kersting, Christoph Rischpler, Patrick Sandach, Justin Ferdinandus, Wolfgang P Fendler, Kambiz Rahbar, Matthias Weckesser, Lale Umutlu, Christine Hanoun, Andreas Huettmann, Hans Christian Reinhardt, Bastian von Tresckow, Ken Herrmann, Ulrich Dührsen, Michael Schäfers
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial. Leukemia 36 (12) (2022)
N George Mikhaeel, Martijn W Heymans, Jakoba Johanna Eertink, Henrica C W de Vet, Ronald Boellaard, Ulrich Dührsen, Luca Ceriani, Christine Schmitz, Sanne Elisabeth Wiegers, Andreas Huettmann, Pieternella J Lugtenburg, Emanuele Zucca, Gerben J C Zwezerijnen, Otto S Hoekstra, Josée J M Zijlstra-Baalbergen, Sally F Barrington
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Catherine Thieblemont, Loic Chartier, Ulrich Dührsen, Umberto Vitolo, Sally F Barrington, Jan M Zaucha, Laetitia Vercellino, Maria Gomes da Silva, Inês Patrocínio Carvalho, Pierre Decazes, Pierre-Julien Viailly, Herve Tilly, Alina Berriolo-Riedinger, René-Olivier Casasnovas, Andreas Huettmann, Hajira Ilyas, N George Mikhaeel, Joel Dunn, Anne-Ségolène Cottereau, Christine Schmitz, Lale Kostakoglu, Joseph N Paulson, Tina Nielsen, Michael Meignan
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma. Blood advances 6 (23) (2022)
Jesko Momotow, Ina Bühnen, Karolin Trautmann-Grill, Guido Kobbe, Dennis Hahn, Roland Schroers, Bernhard Heinrich, Tobias Gaska, Helmut Forstbauer, Burkhard Schmidt, Regina Boger, Andreas Huettmann, Gerhard Heil, Doris M Kraemer, William Krüger, Vanja Zeremski, Norbert Grobe, Kathleen Jentsch-Ullrich, Frank Griesinger, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Paul J Bröckelmann
Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis. British journal of haematology 198 (2) (2022)
Sarah Gillessen, Andreas Huettmann, Vladan Vucinic, Horst Müller, Annette Plütschow, Andreas Viardot, Max S Topp, Carsten Kobe, Boris Böll, Dennis A Eichenauer, Stephanie Sasse, Heinz Haverkamp, Christine Schmitz, Sven Borchmann, Paul J Bröckelmann, Jan-Michel Heger, Michael Fuchs, Andreas Engert, Peter Borchmann, Bastian von Tresckow
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). British journal of haematology (2021)
Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, David Sibon, René-Olivier Casasnovas, Loic Ysebaert, Gandhi Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc André, Alejandro Martin Martin Garcia-Sancho, María Jesus Peñarrubia, Philipp Bernhard Staber, Judith Trotman, Andreas Huettmann, Vittorio Stefoni, Alessandro Re, Philippe Gaulard, Marie-Hélène Delfau-Larue, Laurence de Leval, Michel Meignan, Ju Li, Judith Trotman, Richard Delarue
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
David M Kurtz, Joanne Soo, Lyron Co Ting Keh, Stefan K Alig, Jacob J Chabon, Brian J Sworder, Andre Schultz, Michael C Jin, Florian Scherer, Andrea Garofalo, Charles W Macaulay, Emily G Hamilton, Binbin Chen, Mari Olsen, Joseph G Schroers-Martin, Alexander F M Craig, Everett J Moding, Mohammad S Esfahani, Chih Long Liu, Ulrich Dührsen, Andreas Huettmann, René-Olivier Casasnovas, Jason R Westin, Mark J Roschewski, Wyndham H Wilson, Gianluca Gaidano, Davide Rossi, Maximillian Diehn, Ash A Alizadeh
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nature biotechnology (2021)
Martina Broecker-Preuss, Nina Becher-Boveleth, Stefan P Müller, Andreas Huettmann, Christine Hanoun, Hong Grafe, Julia Richter, Wolfram Klapper, Jan Rekowski, Andreas Bockisch, Ulrich Dührsen
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial. Journal of cancer research and clinical oncology (2021)
Jakoba Johanna Eertink, C N Burggraaff, M W Heymans, U Dührsen, Andreas Huettmann, C Schmitz, S Müller, Pieternella J Lugtenburg, Sally F Barrington, N George Mikhaeel, R Carr, S Czibor, Tamás Györke, Luca Ceriani, Emanuele Zucca, Martin Hutchings, L Kostakoglu, A Loft, S Fanti, Sanne Elisabeth Wiegers, S Pieplenbosch, R Boellaard, O S Hoekstra, Josée J M Zijlstra-Baalbergen, Henrica C W de Vet
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients. Blood advances 5 (9) (2021)
Ulrich Dührsen, Mareike Tometten, Frank Kroschinsky, Arnold Ganser, Stefan Ibach, Stefanie Bertram, Andreas Huettmann
Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma. Blood cancer journal 11 (5) (2021)
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Bernd Keller, Rainer Claus, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas. Blood advances 5 (13) (2021)
Stefan K Alig, Charles W Macaulay, David M Kurtz, Ulrich Dührsen, Andreas Huettmann, Christine Schmitz, Michael C Jin, Brian J Sworder, Andrea Garofalo, Mohammad Shahrokh Esfahani, Barzin Y Nabet, Joanne Soo, Florian Scherer, Alexander F M Craig, René-Olivier Casasnovas, Jason R Westin, Gianluca Gaidano, Davide Rossi, Mark J Roschewski, Wyndham H Wilson, Michel Meignan, Maximilian Diehn, Ash A Alizadeh
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Bettina Wagner, Ulrich Dührsen, Andreas Huettmann, Holger Nückel, Rafael Tomoya Michita, Hana Rohn, Sabine Schramm, Peter A Horn, Vera Rebmann
Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma. Cancers 12 (11) (2020)
Christine Hanoun, Jan Rekowski, Stefan P Müller, Navid Farsijani, Bernd Hertenstein, Christiane Franzius, Ulla von Verschuer, Paul La Rosée, Martin Freesmeyer, Stefan Wilop, Thomas Krohn, Aruna Raghavachar, Arnold Ganser, Frank Michael Bengel, Gabriele Prange-Krex, Frank Kroschinsky, Jörg Kotzerke, Aristoteles Giagounidis, Ulrich Dührsen, Andreas Huettmann
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy. Cancer medicine 9 (22) (2020)
Julia Richter, Andreas Huettmann, Jan Rekowski, Christine Schmitz, Selina Gärtner, Andreas Rosenwald, Martin-Leo Hansmann, Sylvia Hartmann, Peter Möller, Hans-Heinrich Wacker, Alfred Feller, Christoph Thorns, Stefan Müller, Ulrich Dührsen, Wolfram Klapper
Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome. Blood cancer journal 9 (9) (2019)
Alexander Röth, Martin Bommer, Andreas Huettmann, Dörte Herich-Terhürne, Nils Kuklik, Jan Rekowski, Veronika Lenz, Hubert Schrezenmeier, Ulrich Dührsen
Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial. Blood advances 2 (19) (2019)
Maria Sakarou, Lewin Eisele, Ulrich Dührsen, Andreas Huettmann
Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement. European journal of haematology 102 (3) (2019)